Worldwide Adhesion Barrier Market Expected to Reach $1.13 Billion by 2026, Growing at a CAGR of 7.1% from 2018 - ResearchAndMarkets.com

November 8, 2018

DUBLIN--(BUSINESS WIRE)--Nov 8, 2018--The “Adhesion Barrier Market Size, Share & Trends Analysis Report By Product (Synthetic, Natural), By Application (Cardiovascular, Neurological), By Formulation (Film/Mesh, Gel), And Segment Forecasts, 2018 - 2026” report has been added to ResearchAndMarkets.com’s offering.

The global adhesion barrier market size is expected to reach USD 1.13 billion by 2026. The market is estimated to register a CAGR of 7.1% over the forecast period.

Rising geriatric population and prevalence of chronic diseases are the key factors driving the market growth. Increasing awareness regarding the benefits of using adhesion barrier in post-operative procedures is also contributing toward the market growth. Moreover, rising cases of sports-related injuries and number of surgeries would also have a positive impact on the market demand.

Market Dynamics


Rising Geriatric Population Increasing Sports-Related Injuries Increasing Prevalence of Chronic Diseases


Reluctance Towards the Usage of Adhesion Barriers Among Surgeons

Key Findings

The synthetic adhesion barrier segment is anticipated to expand at a lucrative CAGR of over 7% during the forecast period owing to the cost effectiveness of these barriers as compared to the natural adhesion barriers. Hyaluronic acid synthetic adhesion barrier accounted for the largest share in 2017 with a market revenue of USD 147.25 million. Film/mesh formulated adhesion barrier held the largest share in 2017 due to wide use of this formulation. North America led the market in 2017, with a share of more than 47.0%, owing to developed healthcare infrastructure and increased number of surgeries along with customer awareness about the usage of adhesion barrier. Asian countries are estimated to witness the highest growth in market, due to increasing population in the region and changing lifestyle leading to the rising incidences of Cardiovascular Diseases (CVDs) in the region.

Companies Profiled

Johnson & Johnson Sanofi Baxter International Inc. Becton, Dickinson and Company Integra LifeSciences Holdings Corporation Anika Therapeutics Atrium Medical Corporation FzioMed MAST Biosurgery

Key Topics Covered

Chapter 1 Report Scope

Chapter 2 Methodology

Chapter 3 Objectives

Chapter 4 Executive Summary

Chapter 5 Market Definition

Chapter 6 Industry Outlook

Chapter 7 Regulatory & Political Forces

Chapter 8 Competitive & Vendor Landscape

Chapter 9 Product Segment Analysis

Chapter 10 Formulation Segment Analysis

Chapter 11 Application Segment Analysis

Chapter 12 Regional Outlook

Chapter 13 Company Profiles

Chapter 14 KOL Commentary

Chapter 15 Recommendations

For more information about this report visit https://www.researchandmarkets.com/research/hzxsjm/worldwide?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181108005385/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Wound Care



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/08/2018 06:16 AM/DISC: 11/08/2018 06:16 AM


Update hourly